On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Sunday, October 04, 2026

When Liver Signals Stall Late-Stage Pipelines: The Critical Role of Pre-Market DILI (Drug-Induced Liver Injury) Assessment

›
A recent report by BioSpace “ BMS reports liver injury events in lung disease program, with key readout near ” detailing liver injury event...
Sunday, July 26, 2026

Comparative Analysis of Statistical Reporting Guidelines: The New England Journal of Medicine vs. The Lancet

›
Recently, while working on manuscripts submitted to  The New England Journal of Medicine and The Lancet , I had the opportunity to compare ...
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.